Cargando…
Epidermal Growth Factor Receptor-Targeted Neoantigen Peptide Vaccination for the Treatment of Non-Small Cell Lung Cancer and Glioblastoma
The epidermal growth factor receptor (EGFR) plays crucial roles in several important biological functions such as embryogenesis, epithelial tissue development, and cellular regeneration. However, in multiple solid tumor types overexpression and/or activating mutations of the EGFR gene frequently occ...
Autores principales: | Li, Fenge, Wu, Huancheng, Du, Xueming, Sun, Yimo, Rausseo, Barbara Nassif, Talukder, Amjad, Katailiha, Arjun, Elzohary, Lama, Wang, Yupeng, Wang, Zhiyu, Lizée, Gregory |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534925/ https://www.ncbi.nlm.nih.gov/pubmed/37766136 http://dx.doi.org/10.3390/vaccines11091460 |
Ejemplares similares
-
Evolution of CD8(+) T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer
por: Sun, Yimo, et al.
Publicado: (2021) -
Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutations
por: Li, Fenge, et al.
Publicado: (2021) -
Charge-based interactions through peptide position 4 drive diversity of antigen presentation by human leukocyte antigen class I molecules
por: Jackson, Kyle R, et al.
Publicado: (2022) -
Rapid tumor regression in an Asian lung cancer patient following personalized neo-epitope peptide vaccination
por: Li, Fenge, et al.
Publicado: (2016) -
Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
por: Segura-Collar, Berta, et al.
Publicado: (2023)